Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

299
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
299
Hypertension I: Introduction01:28

Hypertension I: Introduction

594
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
594
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

3.6K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.6K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

382
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
382
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

500
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
500
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

1.3K
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic Performance of Routine Abdominal MRI for Detecting Left Ventricular Hypertrophy in ADPKD.

Journal of computer assisted tomography·2026
Same author

Cardio-Thoracic Ratio for Detecting Left Ventricular Hypertrophy on Abdominal MRI in ADPKD.

Journal of magnetic resonance imaging : JMRI·2026
Same author

Author's Reply: Unrecognized Biases and Validation Gaps in TraceOrg for Automated Autosomal Dominant Polycystic Kidney Disease Volumetry.

Journal of the American Society of Nephrology : JASN·2026
Same author

Natural history of simple and complex cysts in autosomal dominant polycystic kidney disease on MRI.

Communications medicine·2026
Same author

Automatically Measuring Kidney, Liver, and Cyst Volumes in Autosomal Dominant Polycystic Kidney Disease.

Journal of the American Society of Nephrology : JASN·2025
Same author

Deep learning-based liver cyst segmentation in MRI for autosomal dominant polycystic kidney disease.

Radiology advances·2025

Related Experiment Video

Updated: Dec 29, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.9K

Hypertension: evolving from standardized to individualized care.

Michael H Alderman1, Jon D Blumenfeld2

  • 1Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx.

Journal of Hypertension
|February 1, 2020
PubMed
Summary

Current hypertension treatment focuses on population averages, but this approach is no longer effective. Personalized blood pressure (BP) management offers a new strategy to improve cardiovascular disease (CVD) prevention efficacy and efficiency.

More Related Videos

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

598
Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness
05:51

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness

Published on: May 3, 2018

18.3K

Related Experiment Videos

Last Updated: Dec 29, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.9K
Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

598
Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness
05:51

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness

Published on: May 3, 2018

18.3K

Area of Science:

  • Cardiovascular Medicine
  • Hypertension Research
  • Preventive Cardiology

Background:

  • The traditional hypertension paradigm, relying on population averages for blood pressure (BP) goals, has significantly reduced cardiovascular disease (CVD) mortality.
  • Progressive lowering of BP thresholds has expanded treatment access but yields diminishing returns and increases adverse events, making further expansion unsustainable.
  • Despite progress, CVD remains a leading cause of death, highlighting the need for improved prevention strategies.

Purpose of the Study:

  • To explore novel scientific approaches for enhancing CVD prevention through personalized BP management.
  • To shift from a one-size-fits-all treatment model to individualized strategies for BP control.
  • To optimize the efficacy and efficiency of BP-related CVD prevention.

Main Methods:

  • Review of current hypertension management paradigms and their limitations.
  • Analysis of emerging scientific evidence supporting individualized BP treatment.
  • Conceptual framework for personalized BP management based on individual characteristics.

Main Results:

  • Current population-based BP management is reaching its limits in reducing CVD mortality.
  • Individualized BP management allows for targeted treatment of high-benefit groups.
  • Personalized strategies can mitigate risks associated with unnecessary therapy and adverse events.

Conclusions:

  • A paradigm shift towards personalized blood pressure management is necessary for advancing CVD prevention.
  • Individualized treatment plans can improve therapeutic efficacy and resource allocation.
  • This approach promises to enhance both the effectiveness and efficiency of preventing BP-related cardiovascular events.